These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3370846)

  • 21. Central mechanisms in DOC-salt hypertensive rats.
    Matsuguchi H; Sharabi FM; O'Connor G; Mark AL; Schmid PG
    Clin Exp Hypertens A; 1982; 4(8):1303-21. PubMed ID: 7116668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paraventricular nucleus lesions attenuate the development of hypertension in DOCA/salt-treated rats.
    Nakata T; Takeda K; Itho H; Hirata M; Kawasaki S; Hayashi J; Oguro M; Sasaki S; Nakagawa M
    Am J Hypertens; 1989 Aug; 2(8):625-30. PubMed ID: 2570597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Roles of brain angiotensin II and C-type natriuretic peptide in deoxycorticosterone acetate-salt hypertension in rats.
    Nishimura M; Ohtsuka K; Sakamoto M; Nanbu A; Takahashi H; Yoshimura M
    J Hypertens; 1998 Aug; 16(8):1175-85. PubMed ID: 9794722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced contractile sensitivity and vasopressin receptor affinity in DOCA-salt hypertension.
    Bockman CS; Jeffries WB; Pettinger WA; Abel PW
    Am J Physiol; 1992 Jun; 262(6 Pt 2):H1752-8. PubMed ID: 1535757
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pressor response to vasopressin and impaired baroreflex function in DOC-salt hypertension.
    Matsuguchi H; Schmid PG
    Am J Physiol; 1982 Jan; 242(1):H44-9. PubMed ID: 7058912
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blockade of angiotensin receptors in the anterior hypothalamic preoptic area lowers blood pressure in DOCA-salt hypertensive rats.
    Kubo T; Yamaguchi H; Tsujimura M; Hagiwara Y; Fukumori R
    Hypertens Res; 2000 Mar; 23(2):109-18. PubMed ID: 10770257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased expression of magnocellular vasopressin mRNA in rats with deoxycorticosterone-acetate induced salt appetite.
    Grillo CA; Saravia F; Ferrini M; Piroli G; Roig P; García SI; de Kloet ER; De Nicola AF
    Neuroendocrinology; 1998 Aug; 68(2):105-15. PubMed ID: 9705577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Are sodium-dependent V1 receptors and sympathetic nerve activations involved in regulation of blood pressure in borderline-hypertensive Hiroshima rats?
    Teranishi Y; Kumazaki T; Miho N; Sugino H; Tsuru H
    Hypertens Res; 2002 Sep; 25(5):763-71. PubMed ID: 12452331
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kinin-mediated antihypertensive effect of captopril in deoxycorticosterone acetate-salt hypertension.
    Chen K; Zhang X; Dunham EW; Zimmerman BG
    Hypertension; 1996 Jan; 27(1):85-9. PubMed ID: 8591894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antihypertensive effects of the essential oil of Alpinia zerumbet and its main constituent, terpinen-4-ol, in DOCA-salt hypertensive conscious rats.
    Lahlou S; Interaminense LF; Leal-Cardoso JH; Duarte GP
    Fundam Clin Pharmacol; 2003 Jun; 17(3):323-30. PubMed ID: 12803571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Central attenuation of aortic baroreceptor reflex in prehypertensive DOCA-salt-loaded rats.
    Nakamura Y; Takeda K; Nakata T; Hayashi J; Kawasaki S; Lee LC; Sasaki S; Nakagawa M; Ijichi H
    Hypertension; 1988 Sep; 12(3):259-66. PubMed ID: 3169941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of sympathetic nervous system in hypotensive action of taurine in DOCA-salt rats.
    Sato Y; Ando K; Fujita T
    Hypertension; 1987 Jan; 9(1):81-7. PubMed ID: 2878880
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of chloride in the sympathetic nervous system in DOCA-salt hypertension.
    Motoyama T; Sano H; Miki T; Suzuki H; Kawaguchi K; Furuta Y; Fukuzaki H
    Am J Hypertens; 1988 Jul; 1(3 Pt 1):287-90. PubMed ID: 3390322
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The significance of vasopressin as a pressor agent.
    Hofbauer KG; Studer W; Mah SC; Michel JB; Wood JM; Stalder R
    J Cardiovasc Pharmacol; 1984; 6 Suppl 2():S429-38. PubMed ID: 6206352
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of centrally administered losartan on deoxycorticosterone-salt hypertension rats.
    Park CG; Leenen FH
    J Korean Med Sci; 2001 Oct; 16(5):553-7. PubMed ID: 11641522
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endocrine control of salt and water excretion: the role of vasopressin in DOCA-salt hypertension.
    Hofbauer KG; Mah SC; Baum HP; Hänni H; Wood JM; Kraetz J
    J Cardiovasc Pharmacol; 1984; 6 Suppl 1():S184-91. PubMed ID: 6204139
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blood pressure effects of intravenous apomorphine in conscious deoxycorticosterone-acetate salt-hypertensive rats.
    Toscano CF; Lahlou S
    J Cardiovasc Pharmacol; 2003 Dec; 42(6):772-81. PubMed ID: 14639100
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of inhibiting brain reactive oxygen species on sympathetic nerve activity in DOCA-salt hypertensive rats].
    Zhang Q; Tan Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Nov; 34(11):1632-6. PubMed ID: 25413063
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mesenteric vascular responses to vasopressin during development of DOCA-salt hypertension in male and female rats.
    Stallone JN
    Am J Physiol; 1995 Jan; 268(1 Pt 2):R40-9. PubMed ID: 7840337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Central catecholamine depletion, vasopressin, and blood pressure in the DOCA/NaCl rat.
    Okuno T; Winternitz SR; Lindheimer MD; Oparil S
    Am J Physiol; 1983 Jun; 244(6):H807-13. PubMed ID: 6407335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.